Vaccines for the prevention of cervical cancer / edited by Peter L. Stern and Henry C. Kitchener.

Contributor(s):

Material type: Text

TextSeries: Oxford oncology libraryPublication details: Oxford : Oxford University Press, 2008.Description: 1 online resource (xix, 149 pages) : color illustrationsContent type:

text

Media type:

computer

Carrier type:

online resource

ISBN:

9780191575457
0191575453
9780191740060
0191740063
0199607184
9780199607181
1283581264
9781283581264
9786613893710
6613893714

Subject(s): Genre/Form:

Electronic books.

Additional physical formats: Print version:: Vaccines for the prevention of cervical cancer.DDC classification:

616.99/466 22

LOC classification:

RC280.U8 V33 2008eb

NLM classification:

QZ 266 V116 2008

Other classification:

44.92

Online resources:

Click here to access online

Contents:

Preface; Contributors; Abbreviations; Glossary; Part 1-Prevention and current treatment; 1 The UK cervical screening programme; 2 Management of cervical intraepithelial neoplasia (CIN); Part 2-HPV and disease; 3 Role of HPV in cervical carcinogenesis; 4 HPV and genital cancer: the essential epidemiology; 5 The role of HPV testing in cervical screening; Part 3-Immune control of HPV infection in cervical neoplasia; 6 Natural immune control of HPV infection; 7 Prophylactic HPV vaccines: pre-clinical and proof of principle studies; 8 Prophylactic HPV vaccination: current status.

9 Introduction of HPV prophylactic vaccinationPart 4-Challenges and future developments; 10 HPV vaccination in the developing world; 11 Screening post vaccination; 12 Second-generation HPV prophylactic vaccines; 13 Therapeutic HPV vaccines; 14 Conclusion; Index; A; B; C; D; E; F; G; H; I; K; L; M; N; O; P; Q; R; S; T; U; V; W; Y.

Action note:

digitized 2011 HathiTrust Digital Library committed to preserve

Summary: Cervical cancer is the second most common form of cancer found in women and it is responsible for more than a quarter of a million deaths worldwide each year. With approximately 70% of cervical cancers now known to be caused by two types of the human papilloma virus (HPV), there is great interest surrounding the approval of the first preventative vaccines for clinical use. Despite this excitement, many questions remain about how the new vaccines should best be implemented and howcervical cancer screening will change following vaccination. Part of the Oxford Oncology Library series, this practic.

Item type:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Home library	Collection	Call number	Materials specified	Status	Date due	Barcode
Electronic-Books	OPJGU Sonepat- Campus	E-Books EBSCO			Available

Includes bibliographical references and index.

Print version record.

Use copy Restrictions unspecified star MiAaHDL

Electronic reproduction. [Place of publication not identified] : HathiTrust Digital Library, 2011. MiAaHDL

Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. MiAaHDL

http://purl.oclc.org/DLF/benchrepro0212

digitized 2011 HathiTrust Digital Library committed to preserve pda MiAaHDL

Cervical cancer is the second most common form of cancer found in women and it is responsible for more than a quarter of a million deaths worldwide each year. With approximately 70% of cervical cancers now known to be caused by two types of the human papilloma virus (HPV), there is great interest surrounding the approval of the first preventative vaccines for clinical use. Despite this excitement, many questions remain about how the new vaccines should best be implemented and howcervical cancer screening will change following vaccination. Part of the Oxford Oncology Library series, this practic.

English.

eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide

There are no comments on this title.

to post a comment.